# Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma

> **NCT04667715** · NA · WITHDRAWN · sponsor: **InSightec**

## Conditions studied

- Glioma

## Interventions

- **DEVICE:** Exablate BBBD

## Key facts

- **NCT ID:** NCT04667715
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-10-23
- **Primary completion:** 2024-10-23
- **Final completion:** 2024-10-23
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Company decision to switch to other trials
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04667715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04667715, "Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04667715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*